First such study in the world aims to find out if Sativex combined with chemotherapy can help treat glioblastoma.
Cancer charities and the NHS are preparing to investigate whether a cannabis-based mouth spray can treat brain tumours and help patients to live longer.
Doctors will give patients across the UK with a recurrent brain tumour called a glioblastoma the drug, which is known as Sativex, alongside a chemotherapy medication – temozolomide – in a clinical trial in an attempt to kill off cancerous cells.
It will be the first such study in the world.
– Read the entire article at The Guardian.
Original Article
